270 related articles for article (PubMed ID: 32954498)
1. Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.
Mollin M; Beaumel S; Vigne B; Brault J; Roux-Buisson N; Rendu J; Barlogis V; Catho G; Dumeril C; Fouyssac F; Monnier D; Gandemer V; Revest M; Brion JP; Bost-Bru C; Jeziorski E; Eitenschenck L; Jarrasse C; Drillon Haus S; Houachée-Chardin M; Hancart M; Michel G; Bertrand Y; Plantaz D; Kelecic J; Traberg R; Kainulainen L; Fauré J; Fieschi F; Stasia MJ
Clin Exp Immunol; 2021 Feb; 203(2):247-266. PubMed ID: 32954498
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
[TBL] [Abstract][Full Text] [Related]
3. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.
Stasia MJ; Bordigoni P; Floret D; Brion JP; Bost-Bru C; Michel G; Gatel P; Durant-Vital D; Voelckel MA; Li XJ; Guillot M; Maquet E; Martel C; Morel F
Hum Genet; 2005 Jan; 116(1-2):72-82. PubMed ID: 15538631
[TBL] [Abstract][Full Text] [Related]
4. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
Martel C; Mollin M; Beaumel S; Brion JP; Coutton C; Satre V; Vieville G; Callanan M; Lefebvre C; Salmon A; Pagnier A; Plantaz D; Bost-Bru C; Eitenschenck L; Durieu I; Floret D; Galambrun C; Chambost H; Michel G; Stephan JL; Hermine O; Blanche S; Blot N; Rubié H; Pouessel G; Drillon-Haus S; Conrad B; Posfay-Barbe KM; Havlicekova Z; Voskresenky-Baricic T; Jadranka K; Arriazu MC; Garcia LA; Sfaihi L; Bordigoni P; Stasia MJ
J Clin Immunol; 2012 Oct; 32(5):942-58. PubMed ID: 22562447
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
[TBL] [Abstract][Full Text] [Related]
7. Variant Type X91
Sun B; Zhu Z; Hui X; Sun J; Wang W; Ying W; Zhou Q; Yao H; Hou J; Wang X
J Clin Immunol; 2022 Oct; 42(7):1564-1579. PubMed ID: 35796921
[TBL] [Abstract][Full Text] [Related]
8. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB.
Stasia MJ; Brion JP; Boutonnat J; Morel F
J Infect Dis; 2003 Nov; 188(10):1593-604. PubMed ID: 14624387
[TBL] [Abstract][Full Text] [Related]
9. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
[TBL] [Abstract][Full Text] [Related]
11. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91(phox) resulting in the rare X91(+) variant of chronic granulomatous disease.
Boog B; Quach A; Costabile M; Smart J; Quinn P; Singh H; Gold M; Booker G; Choo S; Hii CS; Ferrante A
Hum Mutat; 2012 Mar; 33(3):471-5. PubMed ID: 22125116
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail.
Stasia MJ; Lardy B; Maturana A; Rousseau P; Martel C; Bordigoni P; Demaurex N; Morel F
Biochim Biophys Acta; 2002 Apr; 1586(3):316-30. PubMed ID: 11997083
[TBL] [Abstract][Full Text] [Related]
15. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
Front Immunol; 2021; 12():639226. PubMed ID: 33746979
[TBL] [Abstract][Full Text] [Related]
16. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
[TBL] [Abstract][Full Text] [Related]
17. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of X-linked chronic granulomatous disease in Iran.
Teimourian S; Rezvani Z; Badalzadeh M; Kannengiesser C; Mansouri D; Movahedi M; Zomorodian E; Parvaneh N; Mamishi S; Pourpak Z; Moin M
Int J Hematol; 2008 May; 87(4):398-404. PubMed ID: 18322777
[TBL] [Abstract][Full Text] [Related]
19. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).
Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Stasia MJ; Bakri FG; Köker N; Köker MY; Madkaika M; de Boer M; Garcia-Morato MB; Shephard JLV; Roesler J; Kanegane H; Kawai T; Di Matteo G; Shahrooei M; Bustamante J; Rawat A; Vignesh P; Mortaz E; Fayezi A; Cagdas D; Tezcan I; Kitcharoensakkul M; Dinauer MC; Meyts I; Wolach B; Condino-Neto A; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
Blood Cells Mol Dis; 2021 Sep; 90():102587. PubMed ID: 34175765
[TBL] [Abstract][Full Text] [Related]
20. Activation of cryptic splice sites in three patients with chronic granulomatous disease.
de Boer M; van Leeuwen K; Hauri-Hohl M; Roos D
Mol Genet Genomic Med; 2019 Sep; 7(9):e854. PubMed ID: 31364312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
